Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Benitez-Rosario MA et al. - From this analysis, the MMEDRs for patients rotated for side effects at 300 mg/day or more or less than 300 mg/day of morphine were 9.1:1 or 5.6:1, respectively, and the MMEDRs for those switched for pain at 300 mg/day or more or less than 300 mg/day of morphine were 4.9:1 or 3:1, respectively. Both the reasons for opioid rotation and previous morphine doses are predictive factors and should be used to select the MMEDR more accurately.

Today in Pain Management/Palliative Care...keeping you current

Intermittent Cancer Pain: Clinical Importance and an Updated Cancer Pain Classification
American Journal of Hospice and Palliative Medicine, 12/16/09

The Stress Process in Palliative Cancer Care: A Qualitative Study on Informal Caregiving and its Implication for the Delivery of Care
American Journal of Hospice and Palliative Medicine, 12/16/09

Measuring quality of life in pediatric palliative care: challenges and potential solutions
Palliative Medicine, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address